Vertiv Holdings Co

VRT · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.3%

Institutions84.5%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$10.23B	$8.01B	$6.86B	$5.69B	$5.00B	$4.37B	$0	$0
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$6.51B	$5.08B	$4.46B	$4.08B	$3.48B	$2.90B	–	–
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$1.83B	$1.37B	$872.20M	$223.40M	$259.90M	–	–	–
Operating income as a percentage of revenue.	17.9%	17.1%	12.7%	3.9%	5.2%	–	–	–
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$1.33B	$495.80M	$460.20M	$76.60M	$119.60M	-$183.60M	$4.39M	$5.03M
Net income divided by the number of shares outstanding — profit attributable to each share.	$3.49	$1.32	$1.21	$0.20	$0.34	$-0.60	$0.05	$0.06
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$3.41	$1.28	$1.19	$-0.04	$0.33	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$1.73B	$1.23B	$780.40M	$260.60M	$439.10M	$534.60M	–	–
Everything the company owns that has value — cash, property, inventory, investments, and more.	$12.21B	$9.13B	$8.00B	$7.10B	$6.94B	$5.07B	$709.05M	$697.34M
All of the company's interest-bearing borrowings, short and long term combined.	$2.91B	$2.93B	$2.94B	$3.19B	$2.97B	$2.15B	–	–
Everything the company owes — debt, unpaid bills, and other obligations.	$8.27B	$6.70B	$5.98B	$5.65B	$5.52B	$4.41B	$30.75M	$25.43M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$3.94B	$2.43B	$2.01B	$1.44B	$1.42B	$668.30M	$5.00M	$5.00M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$2.11B	$1.32B	$900.50M	-$152.80M	$210.90M	$208.90M	$9.72M	-$710388
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$220.00M	$167.00M	$127.90M	$100.00M	$73.40M	$44.40M	–	–
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$1.89B	$1.15B	$772.60M	-$252.80M	$137.50M	$164.50M	–	–

	You	Peer avg
P/E	63.3	37.0
Revenue Growth	+24.1%	+16.9%
ROE	43.9%	20.7%

Vertiv Holdings Co

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Related Market Insights

McKesson Expands Healthcare Portfolio with $2.25B Precision Medicine Group Acquisition

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison